Evidence map›Paper›PMID 33260510›Full record

ArticlePolymers2020

Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates.

Salvatore Giacomo Marino, Florian Mayer, Alexander Bismarck, Gergely Czél

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Plasma and Polymers: Recent Progress and Trends.Molecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Salvatore Giacomo MarinoDepartment of Polymer Engineering, Faculty of Mechanical Engineering, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary.ORCID 0000-0002-7889-7271
Florian MayerPolymer and Composite Engineering (PaCE) Group, Institute for Materials Chemistry & Research, Faculty of Chemistry, University of Vienna, Währingerstrasse 42, A-1090 Vienna, Austria.ORCID 0000-0003-4934-1896
Alexander BismarckPolymer and Composite Engineering (PaCE) Group, Institute for Materials Chemistry & Research, Faculty of Chemistry, University of Vienna, Währingerstrasse 42, A-1090 Vienna, Austria.
Gergely CzélDepartment of Polymer Engineering, Faculty of Mechanical Engineering, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary.ORCID 0000-0002-6557-0886
Budapest University of Technology and Economics · HUUniversity of Vienna · AT

Funding

European Commission 765881Hungarian Academy of Sciences Premium Postdoctoral Fellowship ProgrammeNational Research, Development and Innovation Office (NRDI, Hungary) BME-IE-NATNational Research, Development and Innovation Office (NRDI, Hungary) OTKA FK 131882
6 · The paper itself

Abstract

Safe, light, and high-performance engineering structures may be generated by adopting composite materials with stable damage process (i.e., without catastrophic delamination). Interlayer hybrid composites may fail stably by suppressing catastrophic interlayer delamination. This paper provides a detailed analysis of delamination occurring in poly(acrylonitrile-butadiene-styrene) (ABS) or polystyrene (PS) film interleaved carbon-glass/epoxy hybrid composites. The ABS films toughened the interfaces of the hybrid laminates, generating materials with higher mode II interlaminar fracture toughness (

Indexed as

delaminationfibre hybrid compositesfilm-interleavingfracture toughnessplasma-treatment

Identifiers

PMID33260510
PMCPMC7759880
OpenAlexW3109639632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.